WSE:POM

Stock Analysis Report

Executive Summary

Polmed S.A. provides medical services to private and institutional clients.

Snowflake

Fundamentals

Flawless balance sheet with solid track record.

Share Price & News

How has Polmed's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

POM

2.9%

PL Healthcare

1.5%

PL Market


1 Year Return

16.5%

POM

32.9%

PL Healthcare

-3.1%

PL Market


Share holder returns

POMIndustryMarket
7 Day0%2.9%1.5%
30 Day0%-0.05%-2.1%
90 Day-0.7%15.6%-7.7%
1 Year16.5%16.5%35.4%32.9%-0.2%-3.1%
3 Year11.3%1.4%10.9%5.0%12.0%4.0%
5 Year27.5%11.5%62.3%51.4%0.2%-11.9%

Price Volatility Vs. Market

How volatile is Polmed's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Polmed undervalued based on future cash flows and its price relative to the stock market?

9.27x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Information is not available.

Information is not available.


Price Based on Earnings

Information is not available.

Information is not available.


Price Based on Expected Growth

Information is not available.


Price Based on Value of Assets

Information is not available.


Next Steps

Future Growth

How is Polmed expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

5.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Information is not available.

Information is not available.

High Growth Earnings: POM's earnings are forecast to grow, but not significantly.

Information is not available.

Information is not available.


Earnings per Share Growth Estimates


Future Return on Equity

Information is not available.


Next Steps

Past Performance

How has Polmed performed over the past 5 years?

27.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Information is not available.

Information is not available.

Information is not available.


Return on Equity

Information is not available.


Return on Assets

Information is not available.


Return on Capital Employed

Information is not available.


Next Steps

Financial Health

How is Polmed's financial position?


Financial Position Analysis

Information is not available.

Information is not available.


Debt to Equity History and Analysis

Information is not available.

Information is not available.

Information is not available.

Information is not available.


Balance Sheet

Information is not available.

Information is not available.


Next Steps

Dividend

What is Polmed's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

company0%marketbottom25%2.6%markettop25%7.3%industryaverage1.9%forecastin3Yearsn/a

Current dividend yield vs market & industry


Dividend Yield and Payments Analysis

Information is not available.

Information is not available.

Stable Dividend: Insufficient data to determine if POM's dividends per share have been stable in the past.

Information is not available.


Current Payout to Shareholders

Information is not available.


Future Payout to Shareholders

Information is not available.


Next Steps

Management

What is the CEO of Polmed's salary, the management and board of directors tenure and is there insider trading?

zł479k

CEO Compensation


CEO

Radoslaw Szubert 0

0yrs

Tenure

zł479,000

Compensation

Mr. Radosaw Szubert serves as the Chairman of the Board at Polmed S.A. 


Insider Trading

Information is not available.


Ownership Breakdown


Management Team

  • Radoslaw Szubert

    Chairman of the Board

    • Tenure: 0yrs
    • Compensation: zł479.00k
  • Romuald Magdon

    Vice President of the Board of Directors

    • Tenure: 0yrs
    • Compensation: zł479.00k
  • Katarzyna Plit-Muszynska

    Sales Director

    • Tenure: 0yrs
  • Alicja Czechowska

    Financial Director

    • Tenure: 0yrs
  • Grazyna Fijal

    Staff Director

    • Tenure: 0yrs
  • Grazyna Jendyk

    Manager of the Board of Directors Office

    • Tenure: 0yrs
  • Dorota Cerowska

    Chief Accountant

    • Tenure: 0yrs

Board Members

  • Krzysztof Plachta (59yo)

    Chairperson of the Supervisory Board

    • Tenure: 0yrs
    • Compensation: zł5.00k
  • Robert Bozyk

    Vice Chairperson of the Supervisory Board

    • Tenure: 0yrs
  • Monika Gaszewska

    Vice President of the Supervisory Board

    • Tenure: 0yrs
    • Compensation: zł4.00k
  • Tomasz Polakowski

    Member of Supervisory Board

    • Tenure: 0yrs
    • Compensation: zł3.00k
  • Boleslaw Rutkowski

    Member of the Supervisory Board

    • Tenure: 0yrs
  • Jacek Dudkiewicz

    Member of Supervisory Board

    • Tenure: 0yrs
    • Compensation: zł4.00k

Company Information

Polmed S.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Polmed S.A.
  • Ticker: POM
  • Exchange: WSE
  • Founded: 1999
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: zł46.654m
  • Shares outstanding: 16.09m
  • Website: https://www.polmed.pl

Number of Employees


Location

  • Polmed S.A.
  • Os.Kopernika 21
  • Starogard Gdanski
  • 83-200
  • Poland

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
POMWSE (Warsaw Stock Exchange)YesCommon Bearer SharesPLPLNDec 2010
0Q3OLSE (London Stock Exchange)YesCommon Bearer SharesGBPLNDec 2010

Biography

Polmed S.A. provides medical services to private and institutional clients. The company offers services, including basic and specialist medical care, full medical diagnostics, rehabilitation, dentistry, ae ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2018/11/27 19:06
End of Day Share Price2018/09/21 00:00
Earnings2018/06/30
Annual Earnings2017/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

© 2018 SIMPLY WALL STREET PTY LTD, COMMUNITY DESIGN 2845206, US DESIGN PATENT #29/544/281, EUROPEAN DESIGN REGISTRATION #2845206, STANDARD & POOR’S FINANCIAL SERVICES LLC. ALL RIGHTS RESERVED.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Copyright © 2018, Standard & Poor’s Financial Services LLC. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. S&P DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of S&P Capital IQ. (2018)